000 01423 a2200385 4500
005 20250517185307.0
264 0 _c20180723
008 201807s 0 0 eng d
022 _a2314-6141
024 7 _a10.1155/2017/8050313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZheng, Haofeng
245 0 0 _aPotential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis.
_h[electronic resource]
260 _bBioMed research international
_c2017
300 _a8050313 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aGene Expression Regulation, Neoplastic
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aProtein Interaction Maps
_xgenetics
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aLiang, Guancan
700 1 _aChen, Yanxiong
700 1 _aLin, Sijie
700 1 _aLiu, Wei
700 1 _aFang, Youqiang
773 0 _tBioMed research international
_gvol. 2017
_gp. 8050313
856 4 0 _uhttps://doi.org/10.1155/2017/8050313
_zAvailable from publisher's website
999 _c27814092
_d27814092